Email updates

Keep up to date with the latest news and articles from Critical Care and BioMed Central.

Highly Accessed Review

Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection - a new frontier?

Arash Afshari1,2, Jacques Schrenzel3, Margareta Ieven4 and Stephan Harbarth1*

Author Affiliations

1 Infection Control Program, Geneva University Hospitals and Medical School, 4, rue Gabrielle-Perret-Gentil, CH-1211 Geneva 14, Switzerland

2 Department of Anaesthesia, Juliane Marie Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Blegdamsvej 9, 2100, Denmark

3 Clinical Microbiology Laboratory, Geneva University Hospitals and Medical School, Geneva, Switzerland

4 University of Antwerp, Vaccine and Infectious Diseases Institute, Laboratory of Medical Microbiology, University Hospital Antwerp, Wilrijkstraat 10 2650, Antwerp, Belgium

For all author emails, please log on.

Critical Care 2012, 16:222 doi:10.1186/cc11202

Published: 29 May 2012

Abstract

Among critically ill patients, the diagnosis of bloodstream infection poses a major challenge. Current standard bacterial identification based on blood culture platforms is intrinsically time-consuming and slow. The continuous evolvement of molecular techniques has the potential of providing a faster, more sensitive and direct identification of causative pathogens without prior need for cultivation. This may ultimately impact clinical decision-making and antimicrobial treatment. This review summarises the currently available technologies, their strengths and limitations and the obstacles that have to be overcome in order to develop a satisfactory bedside point-of-care diagnostic tool for detection of bloodstream infection.